marcusevans press
Evolution Summit 2010
Risk Management in Drug Development
Paul Beninger, Vice President – Pharmacovigilance, Genzyme
| Print article | This entry was posted by admin on 2010/05/05 at 2:04 pm, and is filed under marcus evans Sectors. Follow any responses to this post through RSS 2.0. Responses are currently closed, but you can trackback from your own site. |
Comments are closed.
